APREA THERAPEUTICS, INC.

Transcripts Aprea Therapeutics, Inc.

Equities

APRE

US03836J2015

Market Closed - Nasdaq Other stock markets 01:30:00 08/05/2024 am IST			5-day change	1st Jan Change
5.17 ^USD	-1.71%		+1.37%	+10.00%

02/05	Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza as Chief Medical Officer	CI
10/04	Aprea Therapeutics, Inc. Announces Presentations on Its Next Generation Wee1 Inhibitor, Apr-1051, and A Novel Macrocyclic ATR Inhibitor, ATRN-119, At AACR Annual Meeting 2024	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Aprea Therapeutics, Inc. - Special Call	31/23/31
Transcript : Aprea Therapeutics, Inc. - Special Call	17/22/17
Transcript : Aprea Therapeutics, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-13-2022 11:15 AM	13/22/13
Transcript : Aprea Therapeutics, Inc. - Special Call	06/21/06
Transcript : Aprea Therapeutics, Inc. - Shareholder/Analyst Call	09/21/09
Transcript : Aprea Therapeutics, Inc. - Special Call	22/21/22
Transcript : Aprea Therapeutics, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-12-2021 11:50 AM	13/21/13
Transcript : Aprea Therapeutics, Inc. - Special Call	30/20/30
Transcript : Aprea Therapeutics, Inc. Presents at Morgan Stanley 18th Annual Global Healthcare Conference, Sep-14-2020 02:15 PM	14/20/14
Transcript : Aprea Therapeutics, Inc. Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-14-2020 03:30 PM	15/20/15

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW